BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the remaining $35 million anticipated to close in Q1 2026.BioAtla ...
Experts from Cancer Research UK share how through world-class research, we can better understand and tackle the impacts of ...
Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.
Dec 15 (Reuters) - Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi (SASY.PA), opens new tab to develop therapies for autoimmune diseases in a ...
King Charles III has reached a milestone in his cancer recovery. The British monarch, 77, revealed his treatment for cancer can be reduced in the next year in a personal video message broadcast Friday ...
King Charles III just gave an emotional — and positive — update on his cancer battle. “Today, I am able to share with you the good news that, thanks to early diagnosis, effective intervention and ...
WORCESTER — A promising type of cancer care that’s largely been available only in Boston is coming to central Massachusetts. The state Public Health Council on Wednesday unanimously approved UMass ...
Brookfield, a New York-based investment firm, has agreed to invest $12 billion in green energy projects in Andhra Pradesh (AP), India, over the next three years, including a clean energy-powered ...
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a multistep method for transfecting mouse ...
Dave Coulier is battling cancer — again. The “Full House” actor, 66, said Tuesday that he’s been diagnosed with tongue cancer, several months after saying he had won his battle with Stage 3 ...
Most cancer cells use an enzyme called telomerase to rebuild their telomeres. In this study, Dr. Ashley Harman from CMRI's Cell Biology Unit discovered that a network of tiny fibers inside the cancer ...
Bacteria may be the next frontier in cancer treatment, according to a team led by researchers at Penn State that devised a new approach of creating bacteria-derived mixtures—or cocktails—to help fight ...